David Young insider trades

Open-market stock purchases and sales by David Young, Pres. Research & Development at Processa Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 2, 2010.

Track record: 31% of 13 scored buys are up 5% or more since purchase, averaging +48%.

Recent trades

DateStockTradeValue
Jun 15, 2026PCSA Processa Pharmaceuticals, IncBought$4.6K
May 29, 2026PCSA Processa Pharmaceuticals, IncBought$4.6K
May 15, 2026PCSA Processa Pharmaceuticals, IncBought$4.6K
Apr 30, 2026PCSA Processa Pharmaceuticals, IncBought$4.6K
Apr 15, 2026PCSA Processa Pharmaceuticals, IncBought$4.6K
Mar 31, 2026PCSA Processa Pharmaceuticals, IncBought$4.6K
Jan 1, 2026PCSA Processa Pharmaceuticals, IncBought (not open market)—

Companies traded

  • PCSA Processa Pharmaceuticals, Inc: 15 buys, last Jun 15, 2026
  • QCOR Questcor Pharmaceuticals Inc: 15 sales, last Aug 14, 2014
  • LEDS SemiLEDs Corp: other filings, last Feb 20, 2012

Get free alerts when David Young files a new trade →